Form4insider filings, from the source

SEC Form 4 · accession 0000899243-18-018159

NEOGENOMICS INC · NEO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Jun 25, 2018
Accepted (ET)
Jun 26, 2018 · 5:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series A Convertible Preferred StockF4,F5,F2,F3$7.50Jun 25, 2018J6,864,000D—Dec 30, 2025Common Stock—0I

Explanation of responses

Remarks

Exhibit List: Exhibit 24.1 - Power of Attorney (General Electric Company) Exhibit 24.2 - Power of Attorney (GE Medical Systems Information Technologies, Inc.)